Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility

EU Signs Deal with GSK for Supply of COVID Potential Drug

The contract has been signed by 16 of the 27 EU states. The drug, which is being assessed by the EU medicines regulator and is not authorized yet, can be used for the treatment of coronavirus patients with mild symptoms who do not require supplemental oxygen, the Commission said.

(Reporting by Francesco Guarascio @fraguarascio, editing by Louise Heavens)